nodes	percent_of_prediction	percent_of_DWPC	metapath
Pirenzepine—CHRM5—Amine ligand-binding receptors—HRH3—narcolepsy	0.0317	0.0347	CbGpPWpGaD
Pirenzepine—Mirtazapine—HRH3—narcolepsy	0.0313	0.37	CrCbGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0224	0.0244	CbGpPWpGaD
Pirenzepine—CHRM5—Monoamine GPCRs—HTR2A—narcolepsy	0.0188	0.0206	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0173	0.0189	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0173	0.0189	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—P2RY11—narcolepsy	0.0167	0.0182	CbGpPWpGaD
Pirenzepine—CHRM5—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0158	0.0173	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0155	0.0169	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0155	0.0169	CbGpPWpGaD
Pirenzepine—Clozapine—HRH3—narcolepsy	0.0153	0.181	CrCbGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0149	0.0163	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—HCRT—narcolepsy	0.0142	0.0155	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0134	0.0146	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0134	0.0146	CbGpPWpGaD
Pirenzepine—CHRM1—Monoamine GPCRs—HTR2A—narcolepsy	0.0133	0.0145	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0129	0.0141	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0127	0.0139	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0122	0.0133	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0122	0.0133	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0117	0.0128	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—HCRTR2—narcolepsy	0.0115	0.0125	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—HCRTR1—narcolepsy	0.0115	0.0125	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0114	0.0125	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0114	0.0125	CbGpPWpGaD
Pirenzepine—CHRM1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0111	0.0122	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0111	0.0121	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0109	0.0119	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0109	0.0119	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—TRH—narcolepsy	0.0108	0.0117	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0105	0.0115	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—HCRT—narcolepsy	0.00999	0.0109	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00962	0.0105	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0094	0.0103	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0094	0.0103	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0094	0.0103	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00908	0.00992	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00893	0.00976	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HCRTR1—narcolepsy	0.00871	0.00952	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HCRTR2—narcolepsy	0.00871	0.00952	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—P2RY11—narcolepsy	0.00841	0.00919	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00837	0.00915	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00806	0.0088	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00806	0.0088	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—TAC1—narcolepsy	0.00781	0.00853	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—NPS—narcolepsy	0.00781	0.00853	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00778	0.0085	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00757	0.00827	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00729	0.00796	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HCRT—narcolepsy	0.00715	0.00782	CbGpPWpGaD
Pirenzepine—Mirtazapine—HTR2A—narcolepsy	0.00714	0.0844	CrCbGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00712	0.00778	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00699	0.00763	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00699	0.00763	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00677	0.0074	CbGpPWpGaD
Pirenzepine—Olanzapine—HTR2A—narcolepsy	0.00671	0.0793	CrCbGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00662	0.00723	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—PENK—narcolepsy	0.00638	0.00697	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00624	0.00682	CbGpPWpGaD
Pirenzepine—Thioproperazine—HTR2A—narcolepsy	0.00617	0.073	CrCbGaD
Pirenzepine—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00613	0.0067	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00613	0.0067	CbGpPWpGaD
Pirenzepine—Thiothixene—HTR2A—narcolepsy	0.00607	0.0718	CrCbGaD
Pirenzepine—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00592	0.00647	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.0059	0.00644	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.0055	0.00601	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.0055	0.00601	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00542	0.00592	CbGpPWpGaD
Pirenzepine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00519	0.00567	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00517	0.00565	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00517	0.00565	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00513	0.00561	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.00504	0.0055	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00501	0.00548	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00492	0.00538	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00492	0.00538	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00492	0.00537	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00492	0.00537	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00476	0.00519	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00475	0.00519	CbGpPWpGaD
Pirenzepine—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.0047	0.00513	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00449	0.00491	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00447	0.00488	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00447	0.00488	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0044	0.0048	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00432	0.00472	CbGpPWpGaD
Pirenzepine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0042	0.00459	CbGpPWpGaD
Pirenzepine—Trifluoperazine—HTR2A—narcolepsy	0.0042	0.0496	CrCbGaD
Pirenzepine—Loxapine—HTR2A—narcolepsy	0.00417	0.0493	CrCbGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00404	0.00442	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00394	0.0043	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00394	0.0043	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00382	0.00417	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00367	0.00401	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00364	0.00398	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00364	0.00398	CbGpPWpGaD
Pirenzepine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00363	0.00397	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.0036	0.00394	CbGpPWpGaD
Pirenzepine—Clozapine—HTR2A—narcolepsy	0.0035	0.0414	CrCbGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00347	0.00379	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00347	0.00379	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00335	0.00366	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00335	0.00366	CbGpPWpGaD
Pirenzepine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00331	0.00361	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00327	0.00358	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00315	0.00344	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00315	0.00344	CbGpPWpGaD
Pirenzepine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00311	0.0034	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00306	0.00335	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00304	0.00332	CbGpPWpGaD
Pirenzepine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00296	0.00323	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00285	0.00311	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00278	0.00304	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00277	0.00303	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00277	0.00303	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00269	0.00294	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00264	0.00289	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00264	0.00289	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00259	0.00282	CbGpPWpGaD
Pirenzepine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00256	0.00279	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00255	0.00279	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00254	0.00277	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00244	0.00267	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.00237	0.00259	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.0023	0.00252	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.00223	0.00243	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.00223	0.00243	CbGpPWpGaD
Pirenzepine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00219	0.00239	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00217	0.00237	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00216	0.00236	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.00202	0.00221	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.00202	0.00221	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00196	0.00214	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—PENK—narcolepsy	0.00193	0.00211	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00189	0.00207	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00186	0.00203	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00186	0.00203	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.0018	0.00196	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00172	0.00188	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00167	0.00182	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TRH—narcolepsy	0.00164	0.0018	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00157	0.00171	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.00157	0.00171	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.00153	0.00167	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.00144	0.00157	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.00142	0.00156	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.00142	0.00156	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00136	0.00149	CbGpPWpGaD
Pirenzepine—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.00134	0.00146	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.00122	0.00133	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.00119	0.0013	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—NPS—narcolepsy	0.00119	0.0013	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.00116	0.00126	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.00101	0.00111	CbGpPWpGaD
Pirenzepine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000943	0.00103	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000856	0.000936	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000841	0.000919	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000841	0.000919	CbGpPWpGaD
Pirenzepine—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000719	0.000785	CbGpPWpGaD
Pirenzepine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000506	0.000553	CbGpPWpGaD
